Zoekresultaten - 3 results

Scalable chromatography-based purification of virus-like particle carrier for epitope based influenza A vaccine produced in Escherichia coli.

Synthetic Vaccines, Virus-Like Particle Veterinary Medicine Viral Matrix Proteins Abstract: Virus-like particles (VLP s) are promising molecular structures for the design and construction of novel vaccines, ...

M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A.

Virus-Like Particle Viral Load Abstract: The ectodomain of influenza A matrix protein 2 (M2 e) is a candidate for a universal influenza A vaccine. We used recombinant Hepatitis B core antigen to produce ...

Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening.

therapeutic vaccines. One prophylactic quadrivalent vaccine using L1 virus-like particles (VLP) of HPV 6, 11, 16 and 18 is available on the European market since the end of 2006 and it is expected that a second ...

QR code

QR code for this page URL